Atlas FDA

SENOCLAIRE

FDA premarket approval P130020/S001 · decided 2017-01-05

Approval details

PMA number
P130020
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
SENOCLAIRE
Generic name
Digital breast tomosynthesis
Applicant
GE Healthcare
Date received
2016-07-19
Decision date
2017-01-05
Days to decision
170 days
Decision code
APPR
Product code
OTE
Advisory committee
Radiology
Expedited review
No
Location
Waukesha, WI
Statement
Approval for GE SenoClaire Digital Breast Tomosynthesis system indicated for acquisition of multiple projection views to produce 3D digital mammography images suitable to be used in screening and diagnosis of breast cancer. A screening examination may consist of a 3D DBT image set consisting of a CC and MLO view, and a 2D synthesized image set consisting of a CC and MLO V-Preview images.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
View (K253639)GE Healthcare2026-01-08
MR Contour DL (K242925)GE Healthcare2025-04-01
Digital Expert Access with Remote Scanning (K232346)GE Healthcare2023-10-27
Precision DL (K223212)GE Healthcare2023-04-27
Xeleris V Processing and Review System (K221680)GE Healthcare2023-03-01
Omni Legend (K221932)GE Healthcare2022-09-02
Voluson P6, Voluson P8 (K213689)GE Healthcare2022-02-17
Voluson S6, Voluson S8, Voluson S8t, Voluson S10, Voluson S10 Expert (K213642)GE Healthcare2022-01-13